Is Diabetes Too Profitable to Cure?

Posted on January 7, 2011


Aside from fatter profit margins, in the grand scheme of things, when one compares the margins on chronic medicines to those of specialty medicines (think of things like cancer treatments, which are given quite rarely to a relatively small number of patients), the margins are comparatively low on chronic medicines, but much higher on specialty medications like cancer treatments. Thus, if one could transform a disease like diabetes from being a chronic disease to a curable disease, it’s safe to presume that a curative medicine(s) would be among the world’s biggest blockbusters, making today’s blockbusters like Pfizer’s Lipitor look pretty miniscule by comparison.

full article – Scott’s Web Log

Posted in: Uncategorized